TY - JOUR
T1 - Implementation and Effects of an Information Technology-Based Intervention to Support Speech and Language Therapy Among Stroke Patients With Aphasia: Protocol for a Virtual Randomized Controlled Trial
AU - Kim, Esther S.
AU - Laird, Laura
AU - Wilson, Carlee
AU - Bieg, Till
AU - Mildner, Philip
AU - Möller, Sebastian
AU - Schatz, Raimund
AU - Schwarz, Stephanie
AU - Spang, Robert
AU - Voigt-Antons, Jan-Niklas
AU - Rochon, Elizabeth
N1 - July 2021
PY - 2021
Y1 - 2021
N2 - Background: Mobile app-based therapies are increasingly being employed by speech-language pathologists in the rehabilitation
of people with aphasia as adjuncts or substitutes for traditional in-person therapy approaches. These apps can increase the intensity
of treatment and have resulted in meaningful outcomes across several domains.
Objective: VoiceAdapt is a mobile therapy app designed with user and stakeholder feedback within a user-centered design
framework. VoiceAdapt uses two evidence-based lexical retrieval treatments to help people with aphasia in improving their
naming abilities through interactions with the app. The purpose of the randomized controlled trial (RCT) proposed here is to
examine the feasibility and clinical efficacy of training with VoiceAdapt on the language and communication outcomes of people
with aphasia.
Methods: A multicenter RCT is being conducted at two locations within Canada. A total of 80 people with aphasia will be
recruited to participate in a two-arm, waitlist-controlled, crossover group RCT. After baseline assessment, participants will be
randomized into an intervention group or a waitlist control group. The intervention group participants will engage in 5 weeks of
training with the app, followed by posttreatment and follow-up assessments after an additional 5 weeks. Those in the waitlist
control group will have no training for 5 weeks; this is followed by pretreatment assessment, training for 5 weeks, and posttreatment
assessment. All trial procedures are being conducted remotely given the COVID-19 pandemic.
Results: Recruitment of participants started in September 2020, and the study is expected to be completed by March 2022.
Publication of results is expected within 6 months of study completion.
Conclusions: The results of the RCT will provide information on evidence-based practice using technology-based solutions to
treat aphasia. If positive results are obtained from this RCT, the VoiceAdapt app can be recommended as an efficacious means
of improving lexical retrieval and communicative functioning in people with aphasia in an easily accessible and a cost-effective manner. Moreover, the implementation of this RCT through remote assessment and delivery can provide information to therapists
on telerehabilitation practices and monitoring of app-based home therapy programs.
AB - Background: Mobile app-based therapies are increasingly being employed by speech-language pathologists in the rehabilitation
of people with aphasia as adjuncts or substitutes for traditional in-person therapy approaches. These apps can increase the intensity
of treatment and have resulted in meaningful outcomes across several domains.
Objective: VoiceAdapt is a mobile therapy app designed with user and stakeholder feedback within a user-centered design
framework. VoiceAdapt uses two evidence-based lexical retrieval treatments to help people with aphasia in improving their
naming abilities through interactions with the app. The purpose of the randomized controlled trial (RCT) proposed here is to
examine the feasibility and clinical efficacy of training with VoiceAdapt on the language and communication outcomes of people
with aphasia.
Methods: A multicenter RCT is being conducted at two locations within Canada. A total of 80 people with aphasia will be
recruited to participate in a two-arm, waitlist-controlled, crossover group RCT. After baseline assessment, participants will be
randomized into an intervention group or a waitlist control group. The intervention group participants will engage in 5 weeks of
training with the app, followed by posttreatment and follow-up assessments after an additional 5 weeks. Those in the waitlist
control group will have no training for 5 weeks; this is followed by pretreatment assessment, training for 5 weeks, and posttreatment
assessment. All trial procedures are being conducted remotely given the COVID-19 pandemic.
Results: Recruitment of participants started in September 2020, and the study is expected to be completed by March 2022.
Publication of results is expected within 6 months of study completion.
Conclusions: The results of the RCT will provide information on evidence-based practice using technology-based solutions to
treat aphasia. If positive results are obtained from this RCT, the VoiceAdapt app can be recommended as an efficacious means
of improving lexical retrieval and communicative functioning in people with aphasia in an easily accessible and a cost-effective manner. Moreover, the implementation of this RCT through remote assessment and delivery can provide information to therapists
on telerehabilitation practices and monitoring of app-based home therapy programs.
KW - aphasia; rehabilitation; speech-language pathology; app-based therapy; user-centered design; mHealth; adaptive software
KW - aphasia; rehabilitation; speech-language pathology; app-based therapy; user-centered design; mHealth; adaptive software
U2 - 10.2196/30621
DO - 10.2196/30621
M3 - Article
SN - 1929-0748
VL - 10
JO - JMIR Research Protocols
JF - JMIR Research Protocols
IS - 7
ER -